Manufacturer record
Brilliant Life Sciences Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Brilliant Life Sciences Pvt. Ltd (Gujarat) were declared Not of Standard Quality between April 2020 and December 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: BT1224, Alprazolam Tablets IP 0.5 mg (exp Dec 2025). CDTL Chennai (CDSCO lab) found it not of standard quality: The Sample does not conform to IP Standards with respect to Test for Dissolution only. Listed in the December 2024 alert.
Records by type
2 records linked to Brilliant Life Sciences Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Alprazolam Tablets IP 0.5 mg | Batch BT1224Mfg Jan 2024 · Exp Dec 2025 | The Sample does not conform to IP Standards with respect to Test for Dissolution onlyDissolution | CDTL ChennaiCDSCO lab | Dec 2024 |
| Ofloxacin Tablet I.P. 200 mg | Batch BT4348Mfg Nov 2019 · Exp Oct 2021 | Dissolution & AssayAssay | CDL KolkataCDSCO lab | Apr 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.